Morgan Stanley maintains Centene (NYSE:CNC) with a Overweight and raises the price target from $86 to $109.
Morgan Stanley Maintains Overweight on Centene, Raises Price Target to $109
Morgan Stanley maintains Centene (NYSE:CNC) with a Overweight and raises the price target from $86 to $109.
Related Posts
Kite and Arcellx Close Agreement To Co-Develop And Co-Commercialize Late-Stage Clinical CART-ddBCMA In Multiple Myeloma
Kite, a Gilead Company (NASDAQ:GILD), and Arcellx, Inc. (NASDAQ:ACLX), today announced the closing of the companies' previously announced global strategic collaboration to co-develop and co-commercialize
BMO Capital Maintains Market Perform on Slate Office REIT, Lowers Price Target to C$4.25
BMO Capital analyst Jenny Ma maintains Slate Office REIT (TSX:SOT) with a Market Perform and lowers the price target from C$4.5 to C$4.25.
WideOpenWest Q2 EPS From Continued Operations $0.05 Misses $0.07 Estimate, Sales From Continued Operations $176.10M Miss $177.57M Estimate
WideOpenWest (NYSE:WOW) reported quarterly earnings of $0.05 per share which missed the analyst consensus estimate of $0.07 by 28.57 percent. This is a 66.67 percent decrease over earnings of $0.15 per share from the